title: Glycated hemoglobin as a prognostic risk marker in nondiabetic patients after acute myocardial infarction: what now?
authors.forename: David
authors.initials: D
authors.lastname: Aguilar
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D005500:Follow-Up Studies; D005544:Forecasting; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008687:Metformin / Q000627:therapeutic use; D009026:Mortality; D009203:Myocardial Infarction / Q000097:blood* / Q000517:prevention & control / Q000628:therapy; D058873:Pandemics; D011236:Prediabetic State / Q000097:blood / Q000188:drug therapy; D011379:Prognosis; D012306:Risk
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008687:Metformin